All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YC0039 | Anti-CANT1 (1A1) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 1A1 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0939 | Anti-CANT1 (1A1) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 1A1 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CN091 | Anti-CANT1 (7F8) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 7F8 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CN192 | Anti-CANT1 (7F8) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 7F8 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ0091 | Anti-CANT1 (CBXC-3058) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-3058 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ3515 | Anti-CANT1 (CBXC-3058) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXC-3058 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2649 | Anti-CANT1 (CBFYC-0783) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-0783 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5902 | Anti-CANT1 (CBFYC-0783) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-0783 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0067 | Anti-CANT1 (XHM105) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | XHM105 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0068 | Anti-CANT1 (XHM106) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | XHM106 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2359 | Anti-CANT1 (XHM105) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | XHM105 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2360 | Anti-CANT1 (XHM106) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | XHM106 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION